Not vested. From DBS:-
• Full year results on 12 Nov expected to be within estimates (S$335m, -19% yoy) on earlier write-offs
• $2.1bn of property sales locked in till 2011; estimated to account for c.80% of RNAV (Singapore devt. properties)
• F&B - Target to double non-beer F&B profit in next 5 years
• Reiterate Buy, sum-of-parts TP: S$4.80.
FY09 results on 12 Nov.
We expect earnings to be within our estimates, when it is released on 12 Nov. We are looking at bottomline of S$335m, down c.19% yoy largely on asset impairment and write-downs during 9M YTD.
S$2.1bn unrecognized sales; landbank a key focus. We estimate that the Group has S$2.1bn unrecognized revenue from property development projects sold in Singapore, supporting topline till 2011/12.
This is estimated to account for c.80% of Singapore development property RNAV surplus in our valuation. Landbanking is key, but management is in no hurry given the expected availability of land from Government’s confirmed land sales programme.
Northpoint 2 injection soon?
With market recovery, Northpoint2 is likely to be injected into Frasers Centrepoint Trust soon. This could provide cash inflow of between S$130-170m, to be recycled for further development.
Target to double non-beer F&B profits in 5 years.
Management is looking to grow soft drinks product repertoire and focus on exports, post expiration of Coke bottling agreement. The 20-month transitional agreement from Jan’10 will allow F&N to pursue opportunities currently prohibited. A newly commissioned dairy plant in Thailand will provide capacity to build presence in Indochina and Thailand.
Maintain Buy, TP: S$4.80. Our TP is raised marginally to S$4.80 based on 10% discount to revised RNAV of S$5.45, on higher market value of listed entities. We believe market is undervaluing counter, which is trading at 1x P/B, while a large portion of
development projects has been sold.


